Vmbook Online ordering

Cardax Inc

Cardax Inc (CDXI) is a public company based in the United States that is listed on the over-the-counter (OTC) market. The company operates in the pharmaceutical industry, specifically focused on the development and commercialization of anti-inflammatory dietary supplements and pharmaceutical candidates.

Cardax's flagship product is ZanthoSyn, a dietary supplement containing the antioxidant astaxanthin, which is marketed for its anti-inflammatory and antioxidant properties. The company is currently developing CDX-085, a pharmaceutical candidate derived from astaxanthin, for the treatment of inflammatory diseases.

Cardax was founded in 2004 and is headquartered in Honolulu, Hawaii. The company's stock is traded on the OTCQB market, a market tier of the OTC markets operated by the OTC Markets Group, under the ticker symbol CDXI.

It's important to note that investing in stocks, especially in small and microcap companies like Cardax, involves a higher degree of risk than investing in larger, more established companies. Before making any investment decisions, it's recommended to conduct your own research and consider consulting with a financial advisor.